Frontlight ResearchEarly access
What researchers published on Metastatic breast cancer
30,326 papers, newest first.
Showing 40 of 30,326
CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort.World journal of oncology
Systematic reviewEffects of exercise interventions on cancer-related fatigue and quality of life in patients with metastatic breast cancer: a systematic review and meta-analysis.Frontiers in oncology
ReviewTargeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer.EClinicalMedicine
Case reportRibociclib-induced vitiligo-like depigmentation in a patient with metastatic breast cancer.Dermatology online journal
Designing a Locally Adapted Kader Educational Program to Improve Social Support for Women with Metastatic Breast Cancer in Indonesia.Journal of cancer education : the official journal of the American Association for Cancer Education
Identifying Distant Breast Cancer Recurrence: A Proof-of-Concept Comparison of Discrete-Field Algorithm and Large Language Model Performance and Cost.JCO clinical cancer informatics
Case report[A Case of Pulmonary Metastatic Recurrence of PD-L1-Positive Adenoid Cystic Carcinoma of the Breast Treated with an Immune Checkpoint Inhibitor].Gan to kagaku ryoho. Cancer & chemotherapy
Metastasis-directed therapy for oligoprogressive metastatic breast cancer: a review of current evidence and future research priorities.Annals of palliative medicine
Meta-analysisOutcome-specific differences between randomized trials and real-world studies of CDK4/6 inhibitors in hormone receptor-positive, HER2-negative advanced breast cancer: a meta-epidemiological analysis.BMC cancer
Associations of peripheral neuropathy with patient-reported outcome (PRO) measures in women with breast cancer: from pre-chemotherapy to three or more years post chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Case report[A Case of Multidisciplinary Therapy for Oligometastatic Breast Cancer].Gan to kagaku ryoho. Cancer & chemotherapy
Single-cell multiomics profiling reveals tumour microenvironment landscape and sex-specific immune-suppressive feature in male breast cancer.Clinical and translational medicine
Comparison of five definitions of meaningful change on patient-reported outcomes in four SWOG clinical trials.Journal of patient-reported outcomes
ReviewERα-Targeting PROTACs in Breast Cancer: Structural Design, Biological Mechanisms, Clinical Translation, and Implications for Multimodal Management.Critical reviews in oncology/hematology
Exploring women's perceptions of climate-related environmental stressors and their influence on palliative care experiences and quality of life among women with breast cancer in Ghana: a qualitative descriptive study.BMC palliative care
Dual-database pharmacovigilance analysis based on FAERS and JADER combined with network pharmacology to explore fulvestrant-associated respiratory toxicity.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study.Journal of clinical medicine
Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2- Metastatic Breast Cancer.Cancers
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).Breast (Edinburgh, Scotland)
Early Magnetic Resonance Imaging and Single-Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin-1-Specific Molecular and Liposome Probes.ChemMedChem
An EO771-Derived Metastatic Breast Cancer Model Exhibits RANKL-Associated Osteoimmune Remodeling Before Detectable Bone-Marrow Dissemination.Biology
ReviewRechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.Breast cancer research and treatment
Prognostic Value of Metabolic-Muscle Reserve Index in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine
Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.Oncology
A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells.Cancers
ReviewNavigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
KLRB1 (CD161) as a context-dependent prognostic marker in breast cancer: An exploratory analysis of CD4+ memory T cell infiltration: a retrospective multi-cohort study.Medicine
Addition of tucatinib to trastuzumab/pertuzumab after local therapy for isolated intracranial progression in HER2-positive metastatic breast cancer: primary results of the phase II BRIDGET trial.ESMO open
Pyramid-level training with stain normalization for breast cancer lymph-node metastasis segmentation in whole-slide images.PloS one
Phosphatidylserine modulation influences syncytia formation in human breast cancer cell lines.BMC cancer
Case reportCase report: Fournier's gangrene occurring after inavolisib-induced hyperglycemia in a patient with metastatic breast cancer.Frontiers in pharmacology
Otological manifestations of disseminated metastatic breast cancer presenting with facial nerve palsy, tinnitus and otalgia.BMJ case reports
Metachronous gastric adenocarcinoma during sustained control of metastatic breast cancer.Revista espanola de enfermedades digestivas
ReviewCellular/Molecular-assisted Early Detection of Breast Cancer: An Update.Anti-cancer agents in medicinal chemistry
CT-defined sarcopenia and outcomes in HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Frontiers in medicine
Cost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
Patterns of metastasis according to germline BRCA1/2 mutation status in patients with HER2-negative metastatic breast cancer.Breast cancer research : BCR
Ultra-sensitive MRD assessment in long-term complete responders to anti-HER2 therapy in HER2-positive metastatic breast cancer: initial results from HER2-CR study.ESMO open